TOYODA Hidenori | Department of Gastroenterology, Ogaki Municipal Hospital

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma
Prevalence and characterization of hepatitis C virus genotype 4 in Japanese hepatitis C carriers
Association of hepatitis B virus subgenotypes and basal core promoter/precore region variants with the clinical features of patients with acute hepatitis
Comparison of contrast-enhanced harmonic ultrasonography and power Doppler ultrasonography for depicting vascularity of hepatocellular carcinoma identified by angiography-assisted CT
Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinoma
Simultaneous multicentric occurrence of early hepatocellular carcinoma in a patient with persistent alpha-fetoprotein elevation
High ability to predict the treatment outcome of peginterferon and ribavirin combination therapy based on the reduction in HCV RNA levels at 4 weeks after starting therapy and amino acid substitutions in the hepatitis C virus in patients infected with HCV
Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus

スポンサーリンク